<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> has recently been reported as an aggressive variant of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> with a high incidence of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, but has not been well investigated in terms of survival analysis </plain></SENT>
<SENT sid="1" pm="."><plain>This study analyzed the clinicopathological characteristics, including survival data, of the patients with micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that the aggressive features of micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> might be related to the presence of more <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with stem <z:mp ids='MP_0005384'>cell phenotype</z:mp> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty-five (10%) micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> cases were identified among 561 cases of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We compared the clinicopathological characteristics, including survival data and immunohistochemical profiles of stem cell markers (SOX2, NOTCH3, CD44v6, CD166, ALDH1) of micropapillary <z:mp ids='MP_0002038'>carcinomas</z:mp> with those of randomly selected 112 conventional <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> lacking micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> components (non-micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp>) in the colorectum </plain></SENT>
<SENT sid="5" pm="."><plain>To exclude the possibility of dilution of control group by patients with microsatellite instability-high <z:mp ids='MP_0002038'>carcinomas</z:mp>, we divided non-micropapillary <z:mp ids='MP_0002038'>carcinomas</z:mp> into microsatellite instability-high <z:mp ids='MP_0002038'>carcinoma</z:mp> and microsatellite stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Micropapillary <z:mp ids='MP_0002038'>carcinomas</z:mp> were characterized by more frequent lymphovascular invasion (P&lt;0.0001) and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P&lt;0.0001), higher pathological T and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> stages (P=0.047 and P=0.001), and more frequent SOX2 (P=0.038) and NOTCH3 expressions (P=0.005) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall 5-year survival rate for patients with micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> (37%) was significantly lower than for microsatellite instability-high <z:mp ids='MP_0002038'>carcinoma</z:mp> and microsatellite stable <z:mp ids='MP_0002038'>carcinoma</z:mp> patients (92 and 72%, P&lt;0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>The presence of the micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> component was shown to be associated with a significantly worse survival rate in univariate (P&lt;0.0001) and multivariate (P=0.003, Cox hazard ratio 2.402) analyses </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, recognition of the micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> component in <z:mp ids='MP_0009314'>colonic adenocarcinoma</z:mp> is very important, because the micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp> has been associated with a significantly worse prognosis </plain></SENT>
<SENT sid="10" pm="."><plain>We also found a higher expression rate of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell markers in micropapillary <z:mp ids='MP_0002038'>carcinomas</z:mp>, suggesting their potential contribution to the survival disadvantage of micropapillary <z:mp ids='MP_0002038'>carcinoma</z:mp>.Modern Pathology advance online publication, 12 October 2012; doi:10.1038/modpathol.2012.163 </plain></SENT>
</text></document>